Sign in

Research summary ·

Prevalence of neuropsychiatric and seizure disorders in neurofibromatosis type 1: a systematic review and meta-analysis.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This meta-analysis looked at neurofibromatosis type 1 (NF1). NF1 is linked to learning, behavior and seizure problems. Published rates vary widely. The aim was to estimate how common each problem is. The team pooled studies from MEDLINE, Scopus and Web of Science up to April 2026. They looked at intellectual disability, autism, ADHD, seizures, epilepsy, depression and anxiety. They also looked at a gene subgroup called NF1 microdeletions.

What they found

ADHD was the most common problem in people with NF1. Intellectual disability and ADHD were more common with microdeletions. Rates were also given for autism, seizures, epilepsy, depression and anxiety.

What it means for patients

The authors say NF1 is linked to neuropsychiatric and seizure disorders. They say this backs existing guidance on screening for these problems. They say more research with molecular data is needed.

Why it is not certain yet

Published rates vary widely. Only 2 studies covered the microdeletion subgroup. The authors say more research is needed in that subgroup. Rates for that group rest on small numbers. A pooled analysis can only be as good as the studies in it.

Source

Prevalence of neuropsychiatric and seizure disorders in neurofibromatosis type 1: a systematic review and meta-analysis.

PubMed · PMID 42752999

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Epilepsy publications